Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung

Muscle and Nerve

Volumn 37, Issue 6, 2008, Pages 786-789

  Grommes, Christian ^a   Preston, David C ^a   Al Kadhimi, Zaid ^b   Alshekhlee, Amer ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lambert Eaton; Neuroendocrine carcinoma nerve conduction; Repetitive nerve stimulation

Indexed keywords

ANTIBODY; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN; INTERFERON; PYRIDOSTIGMINE; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ANTIBODY TITER; ARTICLE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EATON LAMBERT SYNDROME; FATIGUE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LARGE CELL CARCINOMA; LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG; LUNG CARCINOMA; LUNG LOBECTOMY; MALE; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME; WEAKNESS;

ACTION POTENTIALS; CARCINOMA, LARGE CELL; ELECTROPHYSIOLOGY; FLUORODEOXYGLUCOSE F18; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POSITRON-EMISSION TOMOGRAPHY; SKIN TEMPERATURE; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 44949112261     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21032     Document Type: Article

References (16)

1. Battafarano RJ, Fernandez FG, Ritter J, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:166-172.
2. Burns TM, Juel VC, Sanders DB, Phillips LH II. Neuroendocrine lung tumors and disorders of the neuromuscular junction. Neurology 1999;52:1490-1491.
3. Chalk CH, Murray NMF, Newsom-Davis J, O'Neill JH, Spiro SG. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small cell lung carcinoma. Neurology 1990;40:1552-1556.
4. Daddi N, Ferolla P, Urbani M, Semeraro A, Avenia N, Ribacchi R, Puma F, Daddi G. Surgical treatment of neuroendocrine tumors of the lung. Eur J Cardiothorac Surg 2004;26:813-817.
5. Demirer T, Ravits J, Aboulafia D. Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma. South Med J 1994;87:1186-189.
6. Gutmann L, Crosby T, Takamori M, Martin J. The Eaton-Lambert syndrome and autoimmune disorders. Am J Med 1972;53:354-356.
7. Keesey J. Electrodiagnostic approach to defects of neuromuscular transmission. Muscle Nerve 1989;12:613-626.
8. Lambert E, Eaton L, Rooke E. Defect of neuromuscular conduction associated with malignant neoplasm. Am J Physiol 1956;187:612-613.
9. Maddison P, Newsom-Davis J, Mills KR, Souhami RL. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 1999;353:117-118.
10. Monstad SE, Drivsholm L, Storstein A, et al. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. J Clin Oncol 2004;22:795-800.
11. O'Neill J, Murray N, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. Brain 1988;111:577-596.
12. Pact M, Cavazza A, Annessi V, Putrino I, Ferrari G, DeFranco S, Sgarbi G. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 2004;77:1163-1167.
13. Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002;37:127-135.
14. Tim RW, Massey JM, Sanders DB. Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients. Ann NY Acad Sci 1998;841:823-826.
15. Wirtz PW, van Dijk JG, van Doom PA, et al. The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands. Neurology 2004;63:397-398.
16. Wirtz PW, Wintzen AR, Verschuuren JJ. Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer. Muscle Nerve 2005;32:226-229.